Combined haptoglobin and hemopexin therapy for the treatment of cardiopulmonary dysfunction in sickle cell disease. - Lucero MJ; Lisk C; Swindle D; Cendali F; Setua S; Thangaraju K; Khan A; Pak DI; O'Boyle Q; Lu S; Tolson R; Zaeske S; et al. (Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2025)